Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroPort NeuroTech Limited ( (HK:2172) ) has provided an update.
MicroPort NeuroTech Limited has entered into a Master Distribution Agreement with MicroPort for a three-year term starting June 27, 2025. This agreement allows MicroPort to commercialize and distribute MicroPort NeuroTech’s neurointerventional medical devices in specified international markets. The agreement is considered a continuing connected transaction due to MicroPort’s significant shareholding in the company. The transaction is subject to certain reporting and review requirements under the Hong Kong Stock Exchange Listing Rules but is exempt from the need for independent shareholder approval. The pricing for the devices will be determined through arm’s length negotiations, ensuring competitiveness with similar products in the market.
More about MicroPort NeuroTech Limited
MicroPort NeuroTech Limited operates in the medical technology industry, focusing on the development and distribution of neurointerventional medical devices. The company is engaged in providing innovative solutions for neurovascular conditions, aiming to enhance patient outcomes and expand its market presence.
Average Trading Volume: 8,853,560
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.78B
For detailed information about 2172 stock, go to TipRanks’ Stock Analysis page.